ALG1L9P

Across TCGA pan-cancer cohorts, ALG1L9P RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of ALG1L9P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where ALG1L9P RNA is repressed in tumor relative to normal tissue. In most cancer types ALG1L9P is over-expressed in tumor, although a few such as KICH and KIRC show the opposite, repressed pattern.

KICH, LIHC, and LUAD are the cancer types where ALG1L9P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ALG1L9P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	III,IV	−0.604	<.001	9	view →
LIHC	Male	All	+0.561	<.001	9	view →
LUAD	Male	All	+0.820	<.001	8	view →
HNSC	All	II,III,IV	+0.354	.006	8	view →
LUSC	Female	All	+0.752	<.001	7	view →
BRCA	All	III,IV	+0.599	<.001	6	view →
CHOL	Male	All	+1.360	<.001	5	view →
READ	All	All	+0.513	.036	5	view →
KIRP	All	II,III,IV	+0.454	.003	5	view →
COAD	All	II,III,IV	+0.290	.006	5	view →
STAD	All	II,III,IV	+0.577	<.001	4	view →
BLCA	All	All	+0.475	.010	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

ALG1L9P–KICH

Open the KICH breakdown →